Hong Kong Pharmaceuticals & Biotech Stocks

  • 7D0.4%
  • 1Y43.4%
  • Avg. PE14.8x
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
3320China Resources Pharmaceutical GroupHK$5.236.3%-19.4%HK$33.3bHK$5.90P/E11.6x13.1%2.1%
1093CSPC Pharmaceutical GroupHK$8.401.6%-13.8%HK$103.3bHK$11.97P/E18.9x10.0%1.4%
867China Medical System HoldingsHK$12.663.4%23.6%HK$31.1bHK$14.76P/E12.6x14.0%3.0%
1061Essex Bio-TechnologyHK$6.2033.0%14.2%HK$3.7bn/aP/E16.1xn/a0%
1477Ocumension TherapeuticsHK$25.104.6%n/aHK$15.5bHK$36.82P/En/an/an/a
570China Traditional Chinese Medicine HoldingsHK$4.752.2%12.0%HK$24.1bHK$4.98P/E13.7x7.8%0%
9966Alphamab OncologyHK$13.501.4%-27.3%HK$13.3bHK$20.73P/E-9.5x40.3%n/a
3933United Laboratories International HoldingsHK$5.891.6%0.7%HK$11.2bHK$8.92P/E14.9x17.7%1.4%
2181MabpharmHK$1.111.8%16.8%HK$4.6bn/aP/E-27.1xn/an/a
512China Grand Pharmaceutical and Healthcare HoldingsHK$6.300.3%19.1%HK$22.6bHK$10.00P/E16.1xn/a1.5%
1558YiChang HEC ChangJiang PharmaceuticalHK$9.250.5%-60.7%HK$8.4bHK$12.91P/E4.4x9.7%5.2%
690Uni-Bio Science GroupHK$0.110.9%-30.1%HK$658.3mn/aP/E-13xn/an/a
897Wai Yuen Tong Medicine HoldingsHK$0.351.4%-1.4%HK$424.9mn/aP/E-2.5xn/a0%
775CK Life Sciences Int'l. (Holdings)HK$0.890%-8.2%HK$8.6bn/aP/E87.4xn/a1.1%
8049Jilin Province Huinan Changlong Bio-pharmacyHK$1.120%-5.9%HK$655.5mn/aP/E3.7xn/a3.7%
239Pak Fah Yeow InternationalHK$1.850%-26.0%HK$576.5mn/aP/E-17.7xn/a2.8%
8247Biosino Bio-Technology and Science IncorporationHK$1.680%-14.3%HK$243.1mn/aP/E25xn/a7.1%
1889Sanai Health Industry GroupHK$0.090%n/aHK$276.1mn/aP/En/an/a0%
455Tianda PharmaceuticalsHK$0.16-1.8%-15.3%HK$354.8mn/aP/E-23.1xn/a0.8%
1498PuraPharmHK$0.75-2.6%-3.8%HK$290.8mn/aP/E-1.4xn/a0%
1011China NT Pharma GroupHK$0.14-3.5%-28.4%HK$274.3mn/aP/En/an/a0%
858Extrawell Pharmaceutical HoldingsHK$0.16-3.1%46.3%HK$380.0mn/aP/E2.8xn/an/a
1666Tong Ren Tang TechnologiesHK$5.50-0.2%-21.5%HK$7.1bHK$7.11P/E19.2x17.7%3.5%
1643Modern Chinese Medicine GroupHK$0.86-3.4%n/aHK$522.0mn/aP/E7.4xn/an/a
Page 1 of 4